MarketCap
Facebook
X
TelegramQuartalsbericht 2023-Q1
hinzugefügt 15.05.2023
Lannett Company Kurshistorie 2011-2026 | LCI
Kurshistorie Jährlich Lannett Company
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.57 | 1.62 | 6.52 | 8.82 | 4.96 | 23.2 | 22.1 | 40.1 | 42.9 | 33.1 | 4.96 | 4.42 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 42.9 | 0.57 | 16.1 |
Kurshistorie anderer Aktien in der Arzneimittelhersteller
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Aerie Pharmaceuticals
AERI
|
7.02 | - | - | $ 754 M |  USA |
 |
Alimera Sciences
ALIM
|
3.97 | - | - | $ 142 M | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
0.86 | - | 7.5 % | $ 6.35 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
0.12 | - | 0.86 % | $ 117 M | USA |
 |
Agile Therapeutics
AGRX
|
0.6 | - | 10.11 % | $ 58.2 M | USA |
 |
Canopy Growth Corporation
CGC
|
1.32 | $ 1.1 | 2.84 % | $ 118 M |  Canada |
 |
Cronos Group
CRON
|
3.69 | $ 2.64 | 1.35 % | $ 1.38 B | Canada |
 |
Catalent
CTLT
|
60 | - | - | $ 11.5 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
7.54 | - | - | $ 2.06 B |  France |
 |
China Pharma Holdings
CPHI
|
0.26 | $ 0.59 | 6.08 % | $ 10.3 M |  China |
 |
DURECT Corporation
DRRX
|
1.21 | - | - | $ 50.1 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
6.3 | $ 3.81 | -16.81 % | $ 53.6 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
26.3 | - | -39.89 % | $ 27.7 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
19.7 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
Endo International plc
ENDP
|
0.29 | - | - | $ 28.9 M |  Irlanda |
 |
Evolus
EOLS
|
4.21 | $ 5.68 | 37.53 % | $ 366 M | USA |
 |
HEXO Corp.
HEXO
|
0.71 | - | 2.45 % | $ 38.1 M | Canada |
 |
Evoke Pharma
EVOK
|
0.67 | - | - | $ 36.6 M | USA |
 |
Harrow Health
HROW
|
52.6 | $ 40.02 | 3.65 % | $ 1.47 B | USA |
 |
Aurora Cannabis
ACB
|
4.08 | $ 3.65 | 4.89 % | $ 86.3 M | Canada |
 |
Athenex
ATNX
|
1.75 | - | -23.39 % | $ 1.76 M | USA |
 |
Jupiter Wellness
JUPW
|
1.52 | - | - | $ 33.6 M | USA |
 |
Emergent BioSolutions
EBS
|
2.71 | $ 8.95 | 0.39 % | $ 458 M | USA |
 |
Assertio Holdings
ASRT
|
0.93 | $ 12.19 | 2.48 % | $ 866 M | USA |
 |
Bausch Health Companies
BHC
|
9.27 | $ 5.67 | -0.87 % | $ 2.07 B | Canada |
 |
Neoleukin Therapeutics
NLTX
|
3.49 | - | - | $ 193 M | Canada |
 |
OrganiGram Holdings
OGI
|
1.58 | $ 1.4 | 2.19 % | $ 402 M | Canada |
 |
Organogenesis Holdings
ORGO
|
3.15 | $ 2.87 | 0.01 % | $ 378 M | USA |
 |
Sundial Growers
SNDL
|
1.45 | $ 1.55 | 1.21 % | $ 3.37 M | Canada |
 |
Perrigo Company plc
PRGO
|
14.2 | $ 11.71 | 2.81 % | $ 1.62 B | USA |
 |
ProPhase Labs
PRPH
|
8.24 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
8.32 | - | - | $ 1.42 B | USA |
 |
Rockwell Medical
RMTI
|
1.52 | $ 0.91 | 1.03 % | $ 21.2 M | USA |
 |
Pacira BioSciences
PCRX
|
25.5 | $ 22.92 | 3.69 % | $ 1.06 B | USA |
 |
PetIQ
PETQ
|
13.6 | - | 1.64 % | $ 400 M | USA |
 |
OptiNose
OPTN
|
1.71 | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
5.05 | - | -27.8 % | $ 2.56 M | USA |
 |
Recro Pharma
REPH
|
1.4 | - | -4.76 % | $ 65.3 M | USA |
 |
Relmada Therapeutics
RLMD
|
5.37 | $ 4.79 | 2.57 % | $ 144 M | USA |
 |
SCYNEXIS
SCYX
|
0.76 | $ 0.76 | 1.22 % | $ 36.4 M | USA |
 |
Solid Biosciences
SLDB
|
5.53 | $ 6.14 | 3.02 % | $ 251 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
2.95 | $ 2.74 | -0.36 % | $ 3.4 M | USA |
 |
Tricida
TCDA
|
7.96 | - | - | $ 3.25 M | USA |
 |
TherapeuticsMD
TXMD
|
2.29 | $ 2.25 | 1.35 % | $ 23.5 M | USA |
 |
Tilray
TLRY
|
1.93 | $ 7.33 | -0.48 % | $ 4.53 B | Canada |
 |
Veru
VERU
|
0.8 | $ 2.53 | 0.4 % | $ 341 M | USA |
 |
Viatris
VTRS
|
15.3 | $ 14.74 | -1.04 % | $ 17.7 B | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
0.44 | - | - | $ 55.5 M | USA |
 |
cbdMD
YCBD
|
0.39 | $ 0.75 | -2.76 % | $ 3.23 M | USA |